Arbutus Biopharma (ABUS) Net Income Growth (5y) (2018 - 2026)
Arbutus Biopharma (ABUS) Net Income Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn |
| 10 | Arbutus Biopharma | 859.36 Mn | 764.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.35% |
| Dec 31, 2025 | 21.85% |
| Sep 30, 2025 | 16.24% |
| Jun 30, 2025 | 16.84% |
| Mar 31, 2025 | -12.09% |
| Dec 31, 2024 | 12.70% |
| Sep 30, 2024 | 24.89% |
| Jun 30, 2024 | 3.17% |
| Mar 31, 2024 | 5.01% |
| Dec 31, 2023 | -1.14% |
| Sep 30, 2023 | 3.86% |
| Jun 30, 2023 | -49.75% |
| Mar 31, 2023 | 1.64% |
| Dec 31, 2022 | 9.40% |
| Sep 30, 2022 | -8.65% |
| Jun 30, 2022 | 4.91% |
| Mar 31, 2022 | 2.59% |
| Dec 31, 2021 | 37.22% |
| Sep 30, 2021 | 0.45% |
| Jun 30, 2021 | 31.65% |